prednisolone has been researched along with Adenocarcinoma, Endometrioid in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Brain metastasis from ovarian cancer, a rare and highly dismal event, develops mostly during or after postoperative chemotherapy." | 1.30 | Brain metastasis as first manifestation of ovarian cancer. ( Imai, A; Matsunami, K; Noda, K; Takagi, H; Tamaya, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsunami, K | 1 |
| Imai, A | 1 |
| Tamaya, T | 1 |
| Takagi, H | 1 |
| Noda, K | 1 |
1 other study available for prednisolone and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Brain metastasis as first manifestation of ovarian cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Endometrioid; Cis | 1999 |